These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

483 related items for PubMed ID: 26476534

  • 1. TAB3 overexpression promotes cell proliferation in non-small cell lung cancer and mediates chemoresistance to CDDP in A549 cells via the NF-κB pathway.
    Chen J, Gu J, Feng J, Liu Y, Xue Q, Ni T, Wang Z, Jia L, Mao G, Ji L.
    Tumour Biol; 2016 Mar; 37(3):3851-61. PubMed ID: 26476534
    [Abstract] [Full Text] [Related]

  • 2. microRNA-381 suppresses the growth and increases cisplatin sensitivity in non-small cell lung cancer cells through inhibition of nuclear factor-κB signaling.
    Huang RS, Zheng YL, Zhao J, Chun X.
    Biomed Pharmacother; 2018 Feb; 98():538-544. PubMed ID: 29287202
    [Abstract] [Full Text] [Related]

  • 3. Cytoplasmic RAP1 mediates cisplatin resistance of non-small cell lung cancer.
    Xiao L, Lan X, Shi X, Zhao K, Wang D, Wang X, Li F, Huang H, Liu J.
    Cell Death Dis; 2017 May 18; 8(5):e2803. PubMed ID: 28518145
    [Abstract] [Full Text] [Related]

  • 4. High expression of PINK1 promotes proliferation and chemoresistance of NSCLC.
    Zhang R, Gu J, Chen J, Ni J, Hung J, Wang Z, Zhang X, Feng J, Ji L.
    Oncol Rep; 2017 Apr 18; 37(4):2137-2146. PubMed ID: 28259921
    [Abstract] [Full Text] [Related]

  • 5. MKP1 repression is required for the chemosensitizing effects of NF-kappaB and PI3K inhibitors to cisplatin in non-small cell lung cancer.
    Cortes-Sempere M, Chattopadhyay S, Rovira A, Rodriguez-Fanjul V, Belda-Iniesta C, Tapia M, Cejas P, Machado-Pinilla R, Manguan-García C, Sánchez-Pérez I, Nistal M, Moratilla C, de Castro-Carpeño J, Gonzalez-Barón M, Albanell J, Perona R.
    Cancer Lett; 2009 Dec 28; 286(2):206-16. PubMed ID: 19553005
    [Abstract] [Full Text] [Related]

  • 6. Overexpression of MYCN promotes proliferation of non-small cell lung cancer.
    Liu K, Wang S, Liu Y, Gu J, Gu S, Xu Z, Zhang R, Wang Z, Ma H, Chen Y, Ji L.
    Tumour Biol; 2016 Sep 28; 37(9):12855-12866. PubMed ID: 27449038
    [Abstract] [Full Text] [Related]

  • 7. TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway.
    Xing Y, Liu Y, Liu T, Meng Q, Lu H, Liu W, Hu J, Li C, Cao M, Yan S, Huang J, Wang T, Cai L.
    Cell Commun Signal; 2018 Jul 31; 16(1):43. PubMed ID: 30064446
    [Abstract] [Full Text] [Related]

  • 8. Curcumin Inhibits Non-Small Cell Lung Cancer Cells Metastasis through the Adiponectin/NF-κb/MMPs Signaling Pathway.
    Tsai JR, Liu PL, Chen YH, Chou SH, Cheng YJ, Hwang JJ, Chong IW.
    PLoS One; 2015 Jul 31; 10(12):e0144462. PubMed ID: 26656720
    [Abstract] [Full Text] [Related]

  • 9. CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner.
    Xie S, Tu Z, Xiong J, Kang G, Zhao L, Hu W, Tan H, Tembo KM, Ding Q, Deng X, Huang J, Zhang Q.
    Oncol Rep; 2017 Feb 31; 37(2):921-928. PubMed ID: 27922681
    [Abstract] [Full Text] [Related]

  • 10. Prostaglandin E2 upregulates β1 integrin expression via the E prostanoid 1 receptor/nuclear factor κ-light-chain-enhancer of activated B cells pathway in non-small-cell lung cancer cells.
    Bai X, Yang Q, Shu W, Wang J, Zhang L, Ma J, Xia S, Zhang M, Cheng S, Wang Y, Leng J.
    Mol Med Rep; 2014 May 31; 9(5):1729-36. PubMed ID: 24584670
    [Abstract] [Full Text] [Related]

  • 11. Cleavage and polyadenylation specific factor 4 targets NF-κB/cyclooxygenase-2 signaling to promote lung cancer growth and progression.
    Yi C, Wang Y, Zhang C, Xuan Y, Zhao S, Liu T, Li W, Liao Y, Feng X, Hao J, Gao Y, Yu W, Chen Y, Zhang C, Guo W, Tang B, Deng W.
    Cancer Lett; 2016 Oct 10; 381(1):1-13. PubMed ID: 27450326
    [Abstract] [Full Text] [Related]

  • 12. High Kpnβ1 expression promotes non-small cell lung cancer proliferation and chemoresistance via the PI3-kinase/AKT pathway.
    Wang H, Wang D, Li C, Zhang X, Zhou X, Huang J.
    Tissue Cell; 2018 Apr 10; 51():39-48. PubMed ID: 29622086
    [Abstract] [Full Text] [Related]

  • 13. CNPY2 enhances resistance to apoptosis induced by cisplatin via activation of NF-κB pathway in human non-small cell lung cancer.
    Yu D, Qin Y, Jun-Qiang L, Shun-Lin G.
    Biomed Pharmacother; 2018 Jul 10; 103():1658-1663. PubMed ID: 29864955
    [Abstract] [Full Text] [Related]

  • 14. CtBP2 promotes proliferation and reduces drug sensitivity in non-small cell lung cancer via the Wnt/β-catenin pathway.
    Wang DP, Gu LL, Xue Q, Chen H, Mao GX.
    Neoplasma; 2018 Nov 15; 65(6):888-897. PubMed ID: 30334447
    [Abstract] [Full Text] [Related]

  • 15. Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling.
    Wang LH, Li Y, Yang SN, Wang FY, Hou Y, Cui W, Chen K, Cao Q, Wang S, Zhang TY, Wang ZZ, Xiao W, Yang JY, Wu CF.
    Br J Cancer; 2014 Jan 21; 110(2):341-52. PubMed ID: 24300974
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3.
    Zhao N, Wang R, Zhou L, Zhu Y, Gong J, Zhuang SM.
    Mol Cancer; 2014 Feb 24; 13():35. PubMed ID: 24565101
    [Abstract] [Full Text] [Related]

  • 17. Overexpressed D2 Dopamine Receptor Inhibits Non-Small Cell Lung Cancer Progression through Inhibiting NF-κB Signaling Pathway.
    Wu XY, Zhang CX, Deng LC, Xiao J, Yuan X, Zhang B, Hou ZB, Sheng ZH, Sun L, Jiang QC, Zhao W.
    Cell Physiol Biochem; 2018 Feb 24; 48(6):2258-2272. PubMed ID: 30114693
    [Abstract] [Full Text] [Related]

  • 18. Loss of TAB3 expression by shRNA exhibits suppressive bioactivity and increased chemical sensitivity of ovarian cancer cell lines via the NF-κB pathway.
    Chen Y, Wang X, Duan C, Chen J, Su M, Jin Y, Deng Y, Wang D, Chen C, Zhou L, Cheng J, Wang W, Xi Q.
    Cell Prolif; 2016 Dec 24; 49(6):657-668. PubMed ID: 27651027
    [Abstract] [Full Text] [Related]

  • 19. Pentraxin 3 acts as a functional effector of Akt/NF-κB signaling to modulate the progression and cisplatin-resistance in non-small cell lung cancer.
    Li Y, Song X, Niu J, Ren M, Tang G, Sun Z, Kong F.
    Arch Biochem Biophys; 2021 Apr 15; 701():108818. PubMed ID: 33617838
    [Abstract] [Full Text] [Related]

  • 20. Nemo-like kinase (NLK) inhibits the progression of NSCLC via negatively modulating WNT signaling pathway.
    Lv L, Wan C, Chen B, Li M, Liu Y, Ni T, Yang Y, Liu Y, Cong X, Mao G, Xue Q.
    J Cell Biochem; 2014 Jan 15; 115(1):81-92. PubMed ID: 23904219
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.